See how much IMO Health could save your organization annually
IMO Studio Login
Contact us
Schedule demo
MollyBookner

Molly Bookner

Content Marketing Manager
Linkedin
Molly Bookner joined IMO Health as a Content Marketing Manager in 2024. Growing up with two physicians – an ER doctor and a pediatrician – Molly has always been fascinated by health topics and passionate about improving the industry. An inquisitive person by nature and a writer at heart, she earned a Master of Science in Journalism from Northwestern University in 2023, with a focus on digital storytelling. When she’s not writing or editing words, Molly can usually be found cursing under her breath in Pilates class, sampling new restaurants across the city, or filming yet another video of her silly cat, Jinx.

More from Molly Bookner

The AHA and IMO Health on integrating AI into clinical workflows – seamlessly

The AHA speaks to Steven Rube, CMO of IMO Health, about how responsible AI can ease clinician burnout and improve decision-making at the point of care.

Stop dirty data at the source: IMO Health + Redox

Discover how IMO Health and Redox ensure clean data from the start to support decision making, insight gathering, and artificial intelligence (AI) downstream.

How Guideline Central and IMO Health are rethinking clinical guidelines

With support from IMO Health, Guideline Central is converting hundreds of clinical guidelines into machine-readable formats. Read about the project here.

USCDI V3 compliance is mandatory by 2026 – here’s how to get ready

The addition of USCDI V3 and V4 to IMO Health’s proprietary lexicon ensures health systems comply with rapidly evolving regulations, avoiding costly penalties.

Inside Cedars-Sinai’s push for smarter LOINC mapping

See how Cedars-Sinai streamlined lab data exchange and improved reporting accuracy through better LOINC mapping.

How do CMS-HCC and HHS-HCC models compare in 2025?

CMS and HHS both use HCCs for risk adjustment, but with different rules, timing, and populations. Learn the key distinctions for 2025.

Invisible patients, fragmented data: How gaps in information obscure rare disease

The gap between rare disease research and care is vast, leading to long diagnostic journeys – especially for pediatric patients. Structured data can help.

Improving clinical outcomes for pediatric patients with rare diseases

Half of U.S. rare disease patients are children – yet most face delayed diagnoses and few treatment options. Here’s how structured data can change that.

What’s new in value-based care? June 2025 key shifts and updates

Explore value-based care news from June 2025: CMS updates, new risk models, leadership shifts, and tech-driven prevention strategies.

Can AI automate scientific literature review? Meet ASCOmind

Discover how AI agents can automate scientific literature review, reducing analysis time from hours to minutes for faster insights and better cancer care.

Real world evidence to insights: Making the invisible visible at ISPOR 2025

At ISPOR 2025, experts explored how GenAI is helping close evidence gaps in rare diseases – turning messy data into reliable, reproducible insights.

Artificial intelligence takes predictive analytics to new heights

Learn how AI is fortifying predictive analytics, from increased accuracy to streamlined workflows.
Load More
Portfolio Overview
IMO Clinical AI
Product finder
IMO Studio

POINT OF CARE WORKFLOW

Problem lists and documentation

IMO Core

Surgical scheduling and OR efficiency

IMO Core Periop

Procedure documentation and coding

IMO Core Procedure

IMO Core global

DATA QUALITY MANAGEMENT

Data standardization and NLP

IMO Precision Normalize

Value set management

IMO Precision Sets

Schedule demo
IMO Studio Login